Glenmark, Solar & Zydus recall merchandise in US for ‘manufacturing deviations’ | India Information – The Instances of India

NEW DELHI: Drug makers Glenmark, Solar Pharma and Zydus are recalling merchandise within the US for manufacturing points, the US Meals and Drug Administration (USFDA) stated in its newest Enforcement Report.
As per the US well being regulator, Mumbai-based Glenmark is recalling over 25 merchandise within the US market as a result of Present Good Manufacturing Observe (CGMP) deviations. A US-based subsidiary of Solar Pharma is recalling round 13,700 bottles of Gabapentin capsules, a medicine used to deal with seizures in folks with epilepsy.